Noval, Romulo T.

HRN: 27-41-84  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2025
CEFTRIAXONE 1G (VIAL)
07/05/2025
07/12/2025
IV
2g
OD
CAP MR, UTI
Waiting Final Action 
07/06/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/06/2025
07/13/2025
IV
2.25g
Q6hrs
CAP-MR
Rejected 
07/13/2025
MUPIROCIN 2%, 15G (TUBE)
07/13/2025
07/28/2025
TOPICAL
2% Solution
BID
Pressure Ulcers
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: